SG Americas Securities LLC Acquires 174,606 Shares of CVS Health Co. (NYSE:CVS)

SG Americas Securities LLC lifted its position in CVS Health Co. (NYSE:CVS - Free Report) by 606.2% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 203,407 shares of the pharmacy operator's stock after purchasing an additional 174,606 shares during the period. SG Americas Securities LLC's holdings in CVS Health were worth $13,781,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Sonora Investment Management Group LLC grew its holdings in shares of CVS Health by 36.9% in the first quarter. Sonora Investment Management Group LLC now owns 7,234 shares of the pharmacy operator's stock worth $490,000 after purchasing an additional 1,950 shares during the last quarter. GAMMA Investing LLC boosted its holdings in CVS Health by 198.5% in the first quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator's stock valued at $1,265,000 after acquiring an additional 12,415 shares in the last quarter. Yousif Capital Management LLC boosted its holdings in CVS Health by 2.8% in the first quarter. Yousif Capital Management LLC now owns 231,834 shares of the pharmacy operator's stock valued at $15,707,000 after acquiring an additional 6,207 shares in the last quarter. Pallas Capital Advisors LLC boosted its holdings in CVS Health by 197.0% in the first quarter. Pallas Capital Advisors LLC now owns 30,877 shares of the pharmacy operator's stock valued at $2,092,000 after acquiring an additional 20,480 shares in the last quarter. Finally, WFA Asset Management Corp boosted its holdings in CVS Health by 47.4% in the first quarter. WFA Asset Management Corp now owns 1,950 shares of the pharmacy operator's stock valued at $132,000 after acquiring an additional 627 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CVS. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a report on Tuesday, February 18th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Royal Bank of Canada raised their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Cowen reissued a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Argus set a $77.00 price objective on CVS Health in a research report on Tuesday, February 18th. Two research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Stock Up 0.9%

Shares of CVS traded up $0.62 during trading hours on Thursday, hitting $66.34. The company had a trading volume of 6,562,248 shares, compared to its average volume of 11,007,901. The firm has a fifty day moving average price of $65.16 and a 200-day moving average price of $60.09. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock has a market capitalization of $83.92 billion, a price-to-earnings ratio of 18.13, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the previous year, the firm earned $1.31 EPS. CVS Health's revenue was up 7.0% on a year-over-year basis. On average, equities research analysts forecast that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio (DPR) is 63.48%.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now owns 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.